<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">0413675</journal-id><journal-id journal-id-type="pubmed-jr-id">4830</journal-id><journal-id journal-id-type="nlm-ta">J Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">J Infect Dis</journal-id><journal-title-group><journal-title>The Journal of infectious diseases</journal-title></journal-title-group><issn pub-type="ppub">0022-1899</issn><issn pub-type="epub">1537-6613</issn></journal-meta><article-meta><article-id pub-id-type="pmid">39535803</article-id><article-id pub-id-type="pmc">12069657</article-id><article-id pub-id-type="doi">10.1093/infdis/jiae562</article-id><article-id pub-id-type="manuscript">HHSPA2074854</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Epidemiologic and Genomic Characterization of an Outbreak of Rift Valley Fever Among Humans and Dairy Cattle in Northern Tanzania</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4023-3928</contrib-id><name><surname>Madut</surname><given-names>Deng B.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Rubach</surname><given-names>Matthew P.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Allan</surname><given-names>Kathryn J.</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1589-8314</contrib-id><name><surname>Thomas</surname><given-names>Kate M.</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>de Glanville</surname><given-names>William A.</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Halliday</surname><given-names>Jo E. B.</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Costales</surname><given-names>Cristina</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3187-5905</contrib-id><name><surname>Carugati</surname><given-names>Manuela</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9181-4023</contrib-id><name><surname>Rolfe</surname><given-names>Robert J.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Bonnewell</surname><given-names>John P.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8909-1508</contrib-id><name><surname>Maze</surname><given-names>Michael J.</given-names></name><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7226-0168</contrib-id><name><surname>Mremi</surname><given-names>Alex R.</given-names></name><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Amsi</surname><given-names>Patrick T.</given-names></name><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Kalengo</surname><given-names>Nathaniel H.</given-names></name><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2319-8246</contrib-id><name><surname>Lyamuya</surname><given-names>Furaha</given-names></name><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Kinabo</surname><given-names>Grace D.</given-names></name><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2365-5072</contrib-id><name><surname>Mbwasi</surname><given-names>Ronald</given-names></name><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Kilonzo</surname><given-names>Kajiru G.</given-names></name><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name><surname>Maro</surname><given-names>Venance P.</given-names></name><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name><surname>Mmbaga</surname><given-names>Blandina T.</given-names></name><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name><surname>Lwezaula</surname><given-names>Bingileki</given-names></name><xref rid="A7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name><surname>Mosha</surname><given-names>Calvin</given-names></name><xref rid="A7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name><surname>Marandu</surname><given-names>Annette</given-names></name><xref rid="A7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name><surname>Kibona</surname><given-names>Tito J.</given-names></name><xref rid="A8" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Feng</given-names></name><xref rid="A9" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><name><surname>Chawla</surname><given-names>Tanu</given-names></name><xref rid="A9" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7287-694X</contrib-id><name><surname>Chia</surname><given-names>Wan Ni</given-names></name><xref rid="A9" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4791-5024</contrib-id><name><surname>Anderson</surname><given-names>Danielle E.</given-names></name><xref rid="A9" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2752-0535</contrib-id><name><surname>Wang</surname><given-names>Lin-Fa</given-names></name><xref rid="A9" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2658-5249</contrib-id><name><surname>Liu</surname><given-names>Jie</given-names></name><xref rid="A10" ref-type="aff">10</xref></contrib><contrib contrib-type="author"><name><surname>Houpt</surname><given-names>Eric R.</given-names></name><xref rid="A11" ref-type="aff">11</xref></contrib><contrib contrib-type="author"><name><surname>Martines</surname><given-names>Roosecelis B.</given-names></name><xref rid="A12" ref-type="aff">12</xref></contrib><contrib contrib-type="author"><name><surname>Zaki</surname><given-names>Sherif R.</given-names></name><xref rid="A12" ref-type="aff">12</xref><xref rid="FN1" ref-type="author-notes">a</xref></contrib><contrib contrib-type="author"><name><surname>Leach</surname><given-names>Austin</given-names></name><xref rid="A13" ref-type="aff">13</xref></contrib><contrib contrib-type="author"><name><surname>Gibbons</surname><given-names>Aridth</given-names></name><xref rid="A13" ref-type="aff">13</xref></contrib><contrib contrib-type="author"><name><surname>Chiang</surname><given-names>Cheng-Feng</given-names></name><xref rid="A13" ref-type="aff">13</xref></contrib><contrib contrib-type="author"><name><surname>Patel</surname><given-names>Ketan</given-names></name><xref rid="A13" ref-type="aff">13</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9933-6193</contrib-id><name><surname>Klena</surname><given-names>John D.</given-names></name><xref rid="A13" ref-type="aff">13</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0456-0959</contrib-id><name><surname>Cleaveland</surname><given-names>Sarah</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4529-102X</contrib-id><name><surname>Crump</surname><given-names>John A.</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Infectious Diseases and International Health, Department of Medicine, Duke University, Durham, North Carolina, USA;</aff><aff id="A2"><label>2</label>Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, United Kingdom;</aff><aff id="A3"><label>3</label>Centre for International Health, University of Otago, Dunedin, New Zealand;</aff><aff id="A4"><label>4</label>Department of Medicine, University of Otago, Christchurch, New Zealand;</aff><aff id="A5"><label>5</label>Kilimanjaro Christian Medical Centre, Moshi, Tanzania;</aff><aff id="A6"><label>6</label>Kilimanjaro Christian Medical University College, Moshi, Tanzania;</aff><aff id="A7"><label>7</label>Mawenzi Regional Referral Hospital, Moshi, Tanzania;</aff><aff id="A8"><label>8</label>Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania;</aff><aff id="A9"><label>9</label>Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore;</aff><aff id="A10"><label>10</label>School of Public Health, Qingdao University, Qingdao, China;</aff><aff id="A11"><label>11</label>Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA;</aff><aff id="A12"><label>12</label>Infectious Diseases Pathology Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA;</aff><aff id="A13"><label>13</label>Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA</aff><author-notes><fn fn-type="deceased" id="FN1"><label>a</label><p id="P1">S. R. Z. deceased.</p></fn><fn fn-type="con" id="FN2"><p id="P2"><bold><italic toggle="yes">Author contributions</italic>.</bold> J. A. C. and M. P. R. conceived the study. J. A. C., M. P. R., and M. C. designed the study protocol. M. P. R., M. C., J. P. B., D. B. M., N. K., F. L., G. D. K., R. M., K. G. K., V. P. M., B. T. M., B. L., C. M., and A. M. implemented and supervised the study. A. L., A. G., C. F. C., K. P., and J. D. K. performed the serologic and molecular testing for RVFV and CCHFV. J. L. and E. R. H. performed the TAC panel. C. C., A. R. M., P. T. A., R. B. M., and S. R. Z. conducted the histopathologic evaluation. K. J. A., K. M. T., W. A. d. G., J. E. B. H., T. J. K., and S. C. conducted livestock enrollment and testing. D. B. M., M. P. R., K. J. A., K. M. T., W. A. d. G., J. E. B. H., C. C., M. C., R. J. R., J. P. B., M. J. M., A. R. M., P. T. A., N. H. K., F. L., G. D. K., R. M., K. G. K., V. P. M., B. T. M., B. L., C. M., A. M., T. J. K., F. Z., T. C., W. N. C., D. E. A., L. W., J. L., E. R. H., R. B. M., S. R. Z., A. L., A. G., C. F. C., K. P., J. D. K., S. C., and J. A. C. were involved in the preparation, writing, and review of this manuscript. All authors were involved in the preparation, writing, and review of this manuscript, and approved the final draft (except for S. R. Z. who passed in November 2021). D. B. M. is responsible for the overall content as guarantor.</p></fn><corresp id="CR1">Correspondence: Deng B. Madut, MD, Division of Infectious Diseases, Duke University, 315 Trent Drive, Hanes House, Room 253, Durham 27710, NC (<email>deng.madut@duke.edu</email>).</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>16</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="ppub"><day>14</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>14</day><month>8</month><year>2025</year></pub-date><volume>232</volume><issue>2</issue><fpage>298</fpage><lpage>307</lpage><permissions><license><license-p>This work is written by (a) US Government employee(s) and is in the public domain in the US.</license-p></license></permissions><abstract id="ABS1"><sec id="S1"><title>Background.</title><p id="P3">A periurban outbreak of Rift Valley fever virus (RVFV) among dairy cattle from May through August 2018 in northern Tanzania was detected through testing samples from prospective livestock abortion surveillance. We sought to identify concurrent human infections, their phylogeny, and epidemiologic characteristics in a cohort of febrile patients enrolled from 2016 to 2019 at hospitals serving the epizootic area.</p></sec><sec id="S2"><title>Methods.</title><p id="P4">From September 2016 through May 2019, we conducted a prospective cohort study that enrolled febrile patients hospitalized at 2 hospitals in Moshi, Tanzania. Archived serum, plasma, or whole blood samples were retrospectively tested for RVFV by PCR. Human samples positive for RVFV were sequenced and compared to RVFV sequences obtained from cattle through a prospective livestock abortion study. Phylogenetic analysis was performed on complete RVFV genomes.</p></sec><sec id="S3"><title>Results.</title><p id="P5">Among 656 human participants, we detected RVFV RNA in 4 (0.6%), including 1 death with hepatic necrosis and other end-organ damage at autopsy. Humans infected with RVFV were enrolled from June through August 2018, and all resided in or near urban areas. Phylogenetic analysis of human and cattle RVFV sequences demonstrated that most clustered to lineage B, a lineage previously described in East Africa. A lineage E strain clustering with lineages in Angola was also identified in cattle.</p></sec><sec id="S4"><title>Conclusions.</title><p id="P6">We provide evidence that an apparently small RVFV outbreak among dairy cattle in northern Tanzania was associated with concurrent severe and fatal infections among humans. Our findings highlight the unidentified scale and diversity of interepizootic RVFV transmission, including near and within an urban area.</p></sec></abstract><kwd-group><kwd>Africa</kwd><kwd>zoonoses</kwd><kwd>Rift Valley fever</kwd><kwd>Crimean-Congo hemorrhagic fever</kwd><kwd>Tanzania</kwd></kwd-group></article-meta></front><body><p id="P7">Rift Valley fever virus (RVFV) is a zoonotic pathogen that belongs to the Phenuviridae family within the order Bunyavirales and causes Rift Valley fever (RVF) in animals and humans. The disease was first described in the Rift Valley of Kenya in 1912, and the etiologic agent was first isolated in 1931 [<xref rid="R1" ref-type="bibr">1</xref>]. The geographic range of the virus is now understood to include most of the African continent and more recently the virus emerged in the Arabian Peninsula [<xref rid="R2" ref-type="bibr">2</xref>]. There is concern for further expansion into naive regions given changing global climatic patterns and the widespread distribution of competent vectors and susceptible hosts. Due to its epidemic potential and lack of countermeasures, RVFV, along with Crimean-Congo hemorrhagic fever (CCHF) virus and others, are listed by the World Health Organization and other global bodies as priority pathogens that need further research and investment [<xref rid="R3" ref-type="bibr">3</xref>].</p><p id="P8">The epidemiology of RVF is characterized by periodic epizootics and epidemics that occur in cycles of 5&#x02013;15 years, generally following periods of heavy rainfall that favor breeding of mosquito vectors [<xref rid="R4" ref-type="bibr">4</xref>]. Infected mosquitoes transmit the virus when taking a blood meal, potentially infecting a wide range of vertebrate hosts. Ruminant livestock are particularly susceptible to RVFV, leading to epizootics with high mortality among young ruminants and large numbers of near-simultaneous abortions among pregnant ruminants, sometimes referred to as &#x0201c;abortion storms&#x0201d; [<xref rid="R5" ref-type="bibr">5</xref>]. Infections in humans typically follow those in livestock, and humans are presumed to be exposed to RVFV through the handling of tissue from infected livestock or less commonly via bites from infected mosquitoes [<xref rid="R4" ref-type="bibr">4</xref>]. Most human infections are asymptomatic or manifest as a mild febrile illness [<xref rid="R5" ref-type="bibr">5</xref>]. However, some infected persons develop severe manifestations, including multiorgan failure and hemorrhagic complications.</p><p id="P9">Epizootics and epidemics are followed by lengthy interepizootic and interepidemic periods (IEP) where clinical disease among animals and humans is often not apparent. For this reason, early studies hypothesized that the virus was principally maintained by vertical transmission within infected <italic toggle="yes">Aedes</italic> mosquito species [<xref rid="R6" ref-type="bibr">6</xref>]. However, this assumption has been challenged due to the demonstration of clinical disease in livestock or humans during the IEP through active surveillance studies and the observation that vertically acquired infections are rapidly diluted in each mosquito generation unless regular amplification between vectors and hosts occurs [<xref rid="R7" ref-type="bibr">7</xref>&#x02013;<xref rid="R9" ref-type="bibr">9</xref>]. Numerous modeling studies now suggest that RVFV maintenance is likely a delicate balance of environmental stochasticity, vertical transmission among mosquitoes, and horizontal transmission between mosquito species and susceptible mammalian hosts [<xref rid="R10" ref-type="bibr">10</xref>&#x02013;<xref rid="R12" ref-type="bibr">12</xref>].</p><p id="P10">In 2018, testing of samples collected from a prospective livestock abortion study detected RVFV infections among 14 dairy cattle in northern Tanzania [<xref rid="R13" ref-type="bibr">13</xref>, <xref rid="R14" ref-type="bibr">14</xref>]. This outbreak occurred outside a major epizootic and was undetected by local surveillance systems. Notable epidemiologic features of this outbreak included detecting infections within a periurban environment and RVFV nucleic acids in the milk of aborting cattle. We hypothesized that RVFV in cattle may have been associated with undetected spillover infections in humans that could shed light on transmission during the IEP.</p><p id="P11">To investigate the epidemiology of RVFV transmission during the IEP and the human health implications of the 2018 cattle outbreak, archived blood samples from participants enrolled in a prospective hospital-based febrile surveillance study in northern Tanzania from 2016 through 2019 were tested for RVFV. We sought to describe any contemporaneous infections in humans and characterize RVFV sequences from cattle and humans. Simultaneous with our evaluation of RVFV IEP infection in humans, we also tested for another arthropod-borne viral zoonosis, CCHF.</p><sec id="S5"><title>METHODS</title><sec id="S6"><title>Study Setting</title><p id="P12">Participants were enrolled in a prospective cohort study to understand the etiologies of febrile illness, including febrile deaths, among hospitalized patients at Kilimanjaro Christian Medical Centre (KCMC) and Mawenzi Regional Referral Hospital (MRRH) in Moshi, Tanzania from 7 September 2016 through 31 May 2019. Some results from this study have been previously published [<xref rid="R15" ref-type="bibr">15</xref>&#x02013;<xref rid="R20" ref-type="bibr">20</xref>]. Moshi (population, &#x0003e;180 000) is the administrative center of the Kilimanjaro Region (population, &#x0003e;1.6 million) and is situated at an elevation of approximately 890 meters above sea level. Typical annual precipitation patterns are characterized by a semiarid climate with a long rainy period from March through May and a shorter rainy period from November through December.</p></sec><sec id="S7"><title>Study Procedures</title><p id="P13">From Monday through Friday during the study period, all pediatric and adult patients presenting to the medical wards of KCMC and MRRH were screened within 24 hours of hospitalization. Patients presenting with a fever were eligible for enrollment if they had a tympanic temperature &#x02265; 38.0&#x000b0;C or a subjective report of fever within the previous 72 hours. After obtaining informed consent, a trained study team member completed standardized case report forms that included age, sex, and village of residence. Participants were also asked to self-report cattle contact based on the question &#x0201c;In the past 30 days, have you lived or worked in close contact with cattle?&#x0201d; Venous whole-blood samples were collected from participants into ethylenediaminetetraacetic acid (EDTA)-preservative tubes and serum separator tubes, and blood specimens were processed, aliquoted, and archived at &#x02212;70&#x000b0;C as EDTA whole blood, EDTA-derived plasma, and serum.</p><p id="P14">In addition to febrile illness surveillance, decedents with a recorded temperature &#x02265; 38.0&#x000b0;C at any time during hospitalization or a subjective report of fever within the 72 hours before hospital admission to KCMC or MRRH were eligible for postmortem examination. Complete diagnostic autopsy was performed upon written authorization by the decedent&#x02019;s family. After obtaining informed consent, a trained study team member administered a standardized questionnaire to the decedent&#x02019;s next of kin to collect age, gender, village of residence, and history of contact with cattle for the decedent. Autopsies were performed by trained pathologists (C. C., A. R. M., P. T. A.) and all were considered infectious regardless of the clinical history. As such, all personnel participating in autopsies wore protective equipment, including scrub suits, protective coveralls, shoe covers, face shields or other protective eyewear, N95 masks, and 2 pairs of gloves. At autopsy, venous blood was collected, processed, and archived similar to that for blood specimens collected antemortem. Pathologists collected tissue samples from the brain, heart, lungs, liver, spleen, and kidneys.</p></sec><sec id="S8"><title>Sample Processing</title><p id="P15">As part of the original study protocol, participant samples were evaluated for a range of infectious diseases, and this has been described in detail elsewhere [<xref rid="R15" ref-type="bibr">15</xref>&#x02013;<xref rid="R18" ref-type="bibr">18</xref>]. To determine the human health implication of the 2018 cattle outbreak, archived human whole blood, serum, and plasma from participants with sufficient samples were shipped on dry ice from Moshi to the Viral Special Pathogens Branch of the United States Centers for Disease Control and Prevention (US CDC) to test for RVFV by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and serology (<xref rid="F1" ref-type="fig">Figure 1</xref>). Decedent tissue samples were also available for RVFV testing by RT-qPCR if RVFV was detected from whole blood, serum, or plasma. To examine the phylogenetic relationship of RVFV detected in humans to that of the contemporaneous cattle outbreak, RNA was extracted from vaginal swabs from the dam, fetal swabs, or placental tissues of the 14 RVFV-infected livestock abortions by RNAeasy Mini Kit (Qiagen) and also shipped from Moshi to the US CDC (<xref rid="F1" ref-type="fig">Figure 1</xref>) [<xref rid="R14" ref-type="bibr">14</xref>].</p><p id="P16">RNA from human samples was extracted using MagMax Pathogen RNA/DNA kit (Thermo Fisher Scientific). RVFV RNA in both human and cattle samples was detected by utilizing assays targeting the L segment (details are given in the <xref rid="SD1" ref-type="supplementary-material">Supplementary Materials</xref>) [<xref rid="R21" ref-type="bibr">21</xref>]. A target against human &#x003b2;&#x02212;2 microglobulin was used to assess human specimen integrity. A bovine GAPDH assay designed to target glyceraldehyde 3-phosphate dehydrogenase mRNA was utilized to assess cattle specimen integrity [<xref rid="R22" ref-type="bibr">22</xref>]. Human and cattle samples with cycle threshold values &#x0003c;32 were considered positive for RVFV and are referred to as &#x0201c;cases&#x0201d; hereafter.</p><p id="P17">While the primary objective of shipping samples to the US CDC was to perform RVFV RT-qPCR and serology, a secondary objective was to test for CCHF virus (CCHFV) RT-qPCR and serology. CCHFV RT-qPCR testing used an assay targeting the NP gene in the S segment (details are given in the <xref rid="SD1" ref-type="supplementary-material">Supplementary Materials</xref>) [<xref rid="R21" ref-type="bibr">21</xref>].</p></sec><sec id="S9"><title>Whole-Genome Sequencing and Phylogenetic Analysis of RVFV-Positive Samples</title><p id="P18">Human samples positive by RT-qPCR for RVFV underwent RNA sequencing. Libraries were constructed using the NEB Ultra II RNA Library Prep kit and sequenced on an Illumina MiSeq (Illumina) or ISEQ100. Geneious Prime version 2022.0.2 was used to map the reads to the RefSeq RVF genome. Cattle samples positive for RVFV were sequenced by amplicon-based sequencing using the Oxford Nanopore MinION instrument (Oxford Nanopore Technologies). Amplicons were trimmed at the 5&#x02032; and 3&#x02032; end before mapping to the RefSeq RVF strain [<xref rid="R23" ref-type="bibr">23</xref>].</p><p id="P19">Phylogenetic analysis was performed on complete RVFV genomes detected from humans and cattle. Alignments were made using Geneious Prime, trimmed to remove ambiguous bases from both ends of all sequences, normalized such that all sequences had the same final length, and exported as phylip alignment files. The trees were generated by submitting phylip alignments to the IQTree web server to generate maximum-likelihood trees with 1000 bootstrap iterations [<xref rid="R24" ref-type="bibr">24</xref>]. Tree figures were generated using the FigTree software version 1.4.4. Node labels represent a bootstrap percentage, and the scale bar shows branch length per unit of 0.01 substitutions per site. Viral lineages were designated as described by Bird et al [<xref rid="R25" ref-type="bibr">25</xref>].</p></sec><sec id="S10"><title>Serology for RVFV and CCHFV</title><p id="P20">Testing for RVFV and CCHFV immunoglobulin G (IgG) was performed using enzyme-linked immunosorbent assays (ELISA) to detect human RVFV and CCHFV virus IgG in serum specimens as originally described for detection of Ebola antibodies by Ksiazek et al and adapted to CCHFV by Bryan et al and RVFV by Shoemaker et al [<xref rid="R26" ref-type="bibr">26</xref>&#x02013;<xref rid="R28" ref-type="bibr">28</xref>]. All serologic testing was performed on samples collected at enrollment.</p></sec><sec id="S11"><title>Additional Laboratory Investigations</title><p id="P21">Participants enrolled antemortem underwent molecular detection for blood pathogens by the TaqMan Array Card (TAC) multiplex for febrile illness [<xref rid="R21" ref-type="bibr">21</xref>]. The TAC panel was performed at the Kilimanjaro Christian Research Institute Biotechnology Laboratory and was specified in the original study protocol before the cattle outbreak was detected. The TAC panel is a real-time PCR-based microfluidic system customized for the current study to detect 20 bacteria, 2 fungi, 3 protozoa, and 19 viruses, including RVFV and CCHFV. Nucleic acid extraction was performed on 800 &#x003bc;L of archived human whole blood samples using the High Pure Viral Nucleic Acid Large Volume Kit (Roche) and eluted in 150 &#x003bc;L with 75 &#x003bc;L subjected to the TAC panel. A sample was considered positive if a reaction yielded cycle threshold values of &#x0003c;35 or &#x0003c;40 if confirmable by plate-based PCR using cognate assays. The confirmatory PCR used the same primer and probe oligonucleotide targets as the targets in the TAC panel design.</p><p id="P22">Whole-blood samples from decedents were sent to Duke-National University of Singapore Medical School for next-generation sequencing analysis as part of the original study protocol. RNA was extracted from whole-blood samples using the Quick-RNA Viral Kit (Zymo Research). RNA was eluted in 15 &#x003bc;L of RNase-free water and used to prepare libraries for next-generation sequencing. Library construction and enrichment were performed using the Twist Comprehensive Virus Research Panel (Twist Bioscience) according to the manufacturer&#x02019;s instructions. The enriched libraries were sent for next-generation sequencing to NovogeneAIT Genomics (NovogeneAIT Genomics Singapore Pte Ltd, Singapore) (details are given in the <xref rid="SD1" ref-type="supplementary-material">Supplementary Materials</xref>).</p></sec><sec id="S12"><title>Statistical Analysis</title><p id="P23">Descriptive analyses were performed using STATA version 16.1 (StataCorp) and R Statistical Software version 4.3.2 (R Core Team 2023; RStudio, Inc). Continuous variables were expressed using means and ranges. Categorical variables were expressed as frequencies.</p></sec><sec id="S13"><title>Research Ethics</title><p id="P24">This study was performed in accordance with the ethical standards of the Helsinki Declaration. Written consent was obtained from all human participants or their next of kin. Ethical approval was obtained from the Research Ethics Committee of Kilimanjaro Christian Medical University College (295); the National Health Research Ethics Review Committee of the National Institute for Medical Research in Tanzania (NIMR/HQ/R.8c/Vol.IX/1000); the University of Otago Ethics Committee (H17/069); the University of Glasgow Medical, Veterinary, and Life Sciences Ethics Committee (200140152 and 20017006); and an Institutional Review Board of Duke University (Pro00016134).</p></sec></sec><sec id="S14"><title>RESULTS</title><sec id="S15"><title>Sociodemographic Characteristics of the Cohort</title><p id="P25">From 7 September 2016 through 31 May 2019, we enrolled 1351 human participants; sufficient samples were available to perform RVFV RT-qPCR in 656 (48.6%) (<xref rid="F1" ref-type="fig">Figure 1</xref>). Of participants who underwent RT-qPCR, 537 (81.9%) were enrolled antemortem and 119 (18.1%) postmortem. Among all participants, mean age was 30 years (range, 1&#x02013;96 years), 302 (46.2%) were female, and 170 (26.2%) reported contact with cattle (<xref rid="T1" ref-type="table">Table 1</xref>).</p></sec><sec id="S16"><title>RT-qPCR for RVFV and CCHFV</title><p id="P26">RVFV was detected by RT-qPCR in serum, plasma, or whole blood from 4 (0.6%) participants, of which 3 (75.0%) were enrolled antemortem and 1 (25.0%) enrolled postmortem. All RVFV RT-qPCR&#x02013;positive participants enrolled antemortem were also positive for RVFV by the TAC pathogen panel and RVFV was likewise detected by next-generation sequencing in the decedent with RVFV detection by RT-qPCR. CCHFV was not detected by RT-qPCR, TAC pathogen panel, or next-generation sequencing among participants who underwent testing.</p><p id="P27">Of RVFV-infected persons, the mean age was 41 years (range, 23&#x02013;57 years), 2 (50.0%) were female, and 3 (75.0%) reported contact with cattle. The dates of enrollment for the 4 human cases were from 29 June through 23 August 2018, and those of the cattle outbreak were from 16 May through 11 August 2018 (<xref rid="F2" ref-type="fig">Figure 2</xref>). Three of the human cases resided in villages of wards within the Kilimanjaro Region. These were the urban wards of Hai Mjini and Pasua and the periurban ward of Kilema Kusini. One human case was from the Manyara Region and resided in the periurban ward of Msitu wa Tembo (<xref rid="F3" ref-type="fig">Figure 3</xref>).</p><p id="P28">A complete diagnostic autopsy was performed on the decedent with RVF and the virus was detected by RT-qPCR in brain, heart, and liver tissue. Detailed review of the medical chart revealed that the decedent suffered a spontaneous abortion within the month before hospitalization and laboratory studies revealed hepatic and renal dysfunction. Gross pathology revealed evidence of hemorrhagic complications with blood visualized in the peritoneal space as well as the small and large intestines. Notable microscopic findings were acute tubular necrosis in the kidneys and fulminant hepatocyte necrosis of the liver.</p></sec><sec id="S17"><title>Serological Testing for RVFV and CCHFV</title><p id="P29">Of 656 participants who underwent serological testing, 8 (1.2%) were positive for anti-RVFV IgG antibodies. Among seropositive participants, mean age was 45 years (range, 14&#x02013;68 years), 2 (25.0%) were female, and 5 (62.5%) reported contact with cattle. Enrollment for 4 seropositive participants occurred in 2017 and the remaining 4 were enrolled from June to July 2018. Of the 4 seropositive participants enrolled from June to July 2018, 2 were RT-qPCR positive for RVFV (<xref rid="T2" ref-type="table">Table 2</xref>).</p><p id="P30">Anti-CCHFV IgG was detected in 5 (0.8%) participants of the 656 who underwent serologic testing. Among seropositive participants, mean age was 45 years (range, 22&#x02013;75 years), 2 (40.0%) were female, and 2 (40.0%) reported cattle contact. No participant was positive for both anti-RVFV IgG and anti-CCHFV IgG.</p></sec><sec id="S18"><title>Phylogenetic Analysis of Human and Cattle RVF Cases</title><p id="P31">Complete RVFV genomes were available for 2 (50.0%) human and 11 (78.6%) cattle infections (<xref rid="F1" ref-type="fig">Figure 1</xref>). Phylogenetic analysis revealed that 10 cattle and the 2 human strains clustered to lineage B. One cattle strain belonged to lineage E and was distinct from the Smithburn livestock vaccine strain (<xref rid="F4" ref-type="fig">Figure 4</xref>).</p></sec></sec><sec id="S19"><title>DISCUSSION</title><p id="P32">We provide evidence that an interepizootic period RVF outbreak identified among dairy cattle in northern Tanzania was associated with contemporaneous severe and fatal infections among humans, undetected by routine RVF surveillance. Phylogenetic analysis revealed that the majority of RVFV strains belonged to a lineage detected in prior epizootics across East Africa. As previously reported and confirmed here, this outbreak is notable for the presence of 2 circulating viral lineages, and the detection of cases within or near urban areas [<xref rid="R14" ref-type="bibr">14</xref>].</p><p id="P33">Phylogenetic analysis revealed that while most strains in this outbreak belonged to RVFV lineage B and were closely related to those from the 2006&#x02013;2007 outbreak in East Africa, 1 livestock abortion sequence clustered to RVFV lineage E [<xref rid="R14" ref-type="bibr">14</xref>, <xref rid="R29" ref-type="bibr">29</xref>]. A large RVFV lineage B outbreak was identified in Kenya in 2006&#x02013;2007 and subsequently involved central and northern Tanzania [<xref rid="R30" ref-type="bibr">30</xref>]. Given the absence of a major recognized epizootic in East Africa since 2007, our findings suggest long-term persistence of lineage B RVFV. Indeed, previous studies examining the ancestry of viruses associated with the 2006&#x02013;2007 outbreak found a direct evolutionary relationship with those identified in the 1997&#x02013;1998 outbreak in East Africa [<xref rid="R29" ref-type="bibr">29</xref>].</p><p id="P34">The livestock abortion strain that clustered to lineage E was distinct from the attenuated RVFV Smithburn vaccine strain and was most closely related to a sequence imported into China from Angola [<xref rid="R14" ref-type="bibr">14</xref>, <xref rid="R31" ref-type="bibr">31</xref>]. We are aware of no specific epidemiologic link between Angola and the study location in northern Tanzania. However, movement or importation of infected livestock is generally hypothesized to be a major mechanism for RVFV emergence in new geographic areas [<xref rid="R32" ref-type="bibr">32</xref>]. Detection of multiple circulating viral lineages has been previously described [<xref rid="R29" ref-type="bibr">29</xref>]. The finding suggests not only that diverse RVFV lineages circulate during the interepizootic period but also pose a risk for RVFV genomic reassortment that has been documented under both natural and experimental conditions [<xref rid="R29" ref-type="bibr">29</xref>, <xref rid="R33" ref-type="bibr">33</xref>]. One particular concern is the emergence of reassortants with altered pathogenicity, transmissibility, vector range, or host range.</p><p id="P35">An epidemiologic feature of this outbreak that requires further discussion was the detection of cases within or near urban areas. Major epizootics have mainly occurred in remote and rural areas, and much of the knowledge learned about interepizootic transmission is the result of studies conducted in such settings [<xref rid="R2" ref-type="bibr">2</xref>]. Recent evidence suggests that urbanization of RVF in sub-Saharan Africa is a concern, especially in rapid and unplanned settlements that produce environmental conditions suitable for mosquitoes and mosquito-borne infections [<xref rid="R34" ref-type="bibr">34</xref>, <xref rid="R35" ref-type="bibr">35</xref>]. Our results indicate that human RVFV infections occur in periurban and urban environments in northern Tanzania; this finding parallels the recent findings of cattle infection in periurban environments in the same catchment [<xref rid="R14" ref-type="bibr">14</xref>]. Such settings may enable new patterns of RVFV transmission that must be understood to develop effective control and prevention strategies.</p><p id="P36">It is notable that we identified no wards with both RVFV-infected cattle and humans; 1 human case also reported no cattle contact. While this may reflect the incomplete coverage of our livestock abortion surveillance and the hospital-based design of our febrile illness research, these findings may suggest that some human infections are acquired through modes of transmission that do not involve direct contact with infected animals. As 1 example, studies suggest that the consumption and handling of raw milk may be a relevant exposure for RVFV transmission [<xref rid="R36" ref-type="bibr">36</xref>]. During the previously described cattle outbreak, we documented evidence of RVFV nucleic acids in the milk of infected dams [<xref rid="R14" ref-type="bibr">14</xref>]. These findings highlight the importance of understanding if animal-source foods may serve as vehicles for RVFV transmission because food value chains originating in rural and periurban areas extend widely beyond these communities and into large urban centers.</p><p id="P37">While testing of whole blood and serum samples by real-time PCR did not detect any acute cases of CCHF, our serologic results identified evidence of past CCHFV infection among 5 participants. CCHF is increasingly recognized as a globally important disease that is associated with case fatality risk of approximately 30&#x02013;40% among hospitalized patients and high risk for transmission in health care settings. Substantial knowledge gaps remain concerning the burden and epidemiology of CCHF in sub-Saharan Africa and further research is needed [<xref rid="R37" ref-type="bibr">37</xref>].</p><p id="P38">Our study has several limitations that warrant further discussion. First, the scale of the outbreak in humans is uncertain because patients with less severe manifestations of RVF may not have presented for hospital care. Thus, interepizootic RVFV transmission may have occurred over a wider spatial scale than reported here due to the limited geographic scope of our surveillance. Second, while our case report form did record contact with cattle, it did not contain more detailed questions on livestock management activities or milk consumption practices that may expose individuals to RVFV. Thus, we were limited in our ability to infer possible modes of transmission to humans. Finally, cases described here occurred following a rainy season in East Africa that was characterized by above-average rainfall [38]. The extent to which the interepizootic/epidemic disease activity described here occurs during periods of low to average rainfall warrants further investigation.</p><p id="P39">In summary, we identified human RVF illnesses, including an autopsy-confirmed RVF death, concurrent with an apparently localized RVF livestock outbreak in the Kilimanjaro Region. These findings suggest there is likely substantial undetected transmission of RVFV during IEPs, and of particular concern is the transmission near and within urban areas. While most RVFV strains belonged to lineage B, the detection of 2 viral strains in an outbreak&#x02014;lineage B, as well as a lineage E strain highly related to RVFV described in Angola&#x02014;suggests complex transmission patterns during the IEP. Our findings indicate that enhanced surveillance and further molecular epidemiologic characterization of RVFV are needed to improve our understanding of RVFV transmission dynamics during the IEP and to inform strategies to prevent RVF epizootics and epidemics. Finally, we found serologic evidence of past CCHFV infection among some participants highlighting the need for further research to define the epidemiology of CCHF in northern Tanzania.</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data"><label>Supplementary material</label><media xlink:href="NIHMS2074854-supplement-Supplementary_material.docx" id="d67e698" position="anchor"/></supplementary-material></sec></body><back><ack id="S21"><title>Acknowledgments.</title><p id="P41">The authors thank those involved in recruitment, laboratory work, data management, and study administration, including Flora W. Mboya, Lilian E. Ngowi, Ephrasia Mariki, Edna Ngowi, Olterere Salimu, Rither Mhela, Jamal Bashiri, Christopher Swai, Jerome Mlangi, Tumsifu G. Tarimo, Edward M. Singo, Stephen Sikumbili, Erica Chuwa, Daniel Mauya, Isaac A. Afwamba, Remigi P. Swai, Augustine M. Musyoka, Rose Oisso, Gershom Mmbwambo, Philoteus A. Sakasaka, Nelson Amani, Victor Mosha, Alphonse S. Mushi, Robert S. Chuwa, Charles Muiruri, Cynthia A. Asiyo, Frank M. Kimaro, and Francis P. Karia. In addition, we thank the study participants as well as the clinical staff and administration at Kilimanjaro Christian Medical Centre and Mawenzi Regional Referral Hospital for their support during this study.</p><sec id="S22"><title>Financial support.</title><p id="P42">This work was supported by the United States National Institutes of Health (NIH; grant numbers 5T32AI007392, D43TW009337, U01 AI062563, R01TW009237, R01 AI121378, and K23 AI116869) for human enrollment; and the University of Edinburgh Supporting Evidence-Based Interventions Project (grant number R83537) and the Biotechnology and Biological Sciences Research Council (grant number BB/R020280/1) for detection of animal cases and collection of samples. D. B. M. received support from the National Institutes of Health Ruth L. Kirschstein National Research Service Award (grant number 5T32AI007392) and the National Institutes of Health Fogarty International Center (grant number D43TW009337).</p></sec></ack><fn-group><fn fn-type="COI-statement" id="FN3"><p id="P43"><bold><italic toggle="yes">Potential conflicts of interest</italic>.</bold> All authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.</p></fn><fn id="FN4"><p id="P44"><bold><italic toggle="yes">Disclaimer</italic>.</bold> The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention. Use of trade names and commercial sources is for identification only and does not imply endorsement by the US Department of Health and Human Services or the US Centers for Disease Control and Prevention.</p></fn><fn id="FN5"><p id="P45">Supplementary Data</p><p id="P46"><ext-link xlink:href="http://academic.oup.com/jid/article-lookup/doi/10.1093/infdis/jiae562" ext-link-type="uri">Supplementary materials</ext-link> are available at <italic toggle="yes">The Journal of Infectious Diseases</italic> online (<ext-link xlink:href="http://jid.oxfordjournals.org/" ext-link-type="uri">http://jid.oxfordjournals.org/</ext-link>). <xref rid="SD1" ref-type="supplementary-material">Supplementary materials</xref> consist of data provided by the author that are published to benefit the reader. The posted materials are not copyedited. The contents of all <xref rid="SD1" ref-type="supplementary-material">supplementary data</xref> are the sole responsibility of the authors. Questions or messages regarding errors should be addressed to the author.</p></fn><fn id="FN6"><p id="P47">Presented in part: 11th International Conference on Emerging Infectious Diseases, 7&#x02013;10 August 2022, Atlanta, GA, abstract P364; and 71st Annual Meeting of the American Society of Tropical Medicine and Hygiene, 30 October&#x02013;3 November 2022, Seattle, WA, abstract LB-5146.</p></fn></fn-group><sec sec-type="data-availability" id="S20"><title>Data sharing.</title><p id="P40">Data collected for the study include individual participant data and a data dictionary defining each field in the set. These will be made available in the form of deidentified data upon a reasonable request made to the corresponding author. Access will be subject to Tanzanian regulations and institutional review board approvals.</p></sec><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><name><surname>Daubney</surname><given-names>R</given-names></name>, <name><surname>Hudson</surname><given-names>JR</given-names></name>, <name><surname>Garnham</surname><given-names>PC</given-names></name>. <article-title>Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep cattle and man from East Africa</article-title>. <source>J Pathol Bacteriol</source>
<year>1931</year>; <volume>34</volume>:<fpage>545</fpage>&#x02013;<lpage>79</lpage>.</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>Bron</surname><given-names>GM</given-names></name>, <name><surname>Strimbu</surname><given-names>K</given-names></name>, <name><surname>Cecilia</surname><given-names>H</given-names></name>, <etal/>
<article-title>Over 100 years of rift valley fever: a patchwork of data on pathogen spread and spillover</article-title>. <source>Pathog Basel Switz</source>
<year>2021</year>; <volume>10</volume>:<fpage>708</fpage>.</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Mehand</surname><given-names>MS</given-names></name>, <name><surname>Al-Shorbaji</surname><given-names>F</given-names></name>, <name><surname>Millett</surname><given-names>P</given-names></name>, <name><surname>Murgue</surname><given-names>B</given-names></name>. <article-title>The WHO R&#x00026;D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts</article-title>. <source>Antiviral Res</source>
<year>2018</year>; <volume>159</volume>:<fpage>63</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">30261226</pub-id>
</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Nanyingi</surname><given-names>MO</given-names></name>, <name><surname>Munyua</surname><given-names>P</given-names></name>, <name><surname>Kiama</surname><given-names>SG</given-names></name>, <etal/>
<article-title>A systematic review of Rift Valley fever epidemiology 1931&#x02013;2014</article-title>. <source>Infect Ecol Epidemiol</source>
<year>2015</year>; <volume>5</volume>:<fpage>28024</fpage>.<pub-id pub-id-type="pmid">26234531</pub-id>
</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Gerdes</surname><given-names>GH</given-names></name>. <article-title>Rift Valley fever</article-title>. <source>Rev Sci Tech</source>
<year>2004</year>; <volume>23</volume>: <fpage>613</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="pmid">15702723</pub-id>
</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Pepin</surname><given-names>M</given-names></name>, <name><surname>Bouloy</surname><given-names>M</given-names></name>, <name><surname>Bird</surname><given-names>BH</given-names></name>, <name><surname>Kemp</surname><given-names>A</given-names></name>, <name><surname>Paweska</surname><given-names>J</given-names></name>. <article-title>Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention</article-title>. <source>Vet Res</source>
<year>2010</year>; <volume>41</volume>:<fpage>61</fpage>.<pub-id pub-id-type="pmid">21188836</pub-id>
</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Romoser</surname><given-names>WS</given-names></name>, <name><surname>Oviedo</surname><given-names>MN</given-names></name>, <name><surname>Lerdthusnee</surname><given-names>K</given-names></name>, <etal/>
<article-title>Rift Valley fever virus-infected mosquito ova and associated pathology: possible implications for endemic maintenance</article-title>. <source>Res Rep Trop Med</source>
<year>2011</year>; <volume>2</volume>:<fpage>121</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">30881185</pub-id>
</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Kariuki Njenga</surname><given-names>M</given-names></name>, <name><surname>Bett</surname><given-names>B</given-names></name>. <article-title>Rift Valley fever virus&#x02014;how and where virus is maintained during inter-epidemic periods</article-title>. <source>Curr Clin Microbiol Rep</source>
<year>2019</year>; <volume>6</volume>:<fpage>18</fpage>&#x02013;<lpage>24</lpage>.</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Lipsitch</surname><given-names>M</given-names></name>, <name><surname>Nowak</surname><given-names>MA</given-names></name>, <name><surname>Ebert</surname><given-names>D</given-names></name>, <name><surname>May</surname><given-names>RM</given-names></name>. <article-title>The population dynamics of vertically and horizontally transmitted parasites</article-title>. <source>Proc Biol Sci</source>
<year>1995</year>; <volume>260</volume>:<fpage>321</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">7630898</pub-id>
</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Pedro</surname><given-names>SA</given-names></name>, <name><surname>Abelman</surname><given-names>S</given-names></name>, <name><surname>Ndjomatchoua</surname><given-names>FT</given-names></name>, <name><surname>Sang</surname><given-names>R</given-names></name>, <name><surname>Tonnang</surname><given-names>HEZ</given-names></name>. <article-title>Stability, bifurcation and chaos analysis of vector-borne disease model with application to Rift Valley fever</article-title>. <source>PLoS One</source>
<year>2014</year>; <volume>9</volume>:<fpage>e108172</fpage>.<pub-id pub-id-type="pmid">25271641</pub-id>
</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Pedro</surname><given-names>SA</given-names></name>, <name><surname>Abelman</surname><given-names>S</given-names></name>, <name><surname>Tonnang</surname><given-names>HEZ</given-names></name>. <article-title>Predicting Rift Valley fever inter-epidemic activities and outbreak patterns: insights from a stochastic host-vector model</article-title>. <source>PLoS Negl Trop Dis</source>
<year>2016</year>; <volume>10</volume>:<fpage>e0005167</fpage>.<pub-id pub-id-type="pmid">28002417</pub-id>
</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Manore</surname><given-names>CA</given-names></name>, <name><surname>Beechler</surname><given-names>BR</given-names></name>. <article-title>Inter-epidemic and between-season persistence of Rift Valley fever: vertical transmission or cryptic cycling?</article-title>
<source>Transbound Emerg Dis</source>
<year>2015</year>; <volume>62</volume>:<fpage>13</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="pmid">23551913</pub-id>
</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Thomas</surname><given-names>KM</given-names></name>, <name><surname>Kibona</surname><given-names>T</given-names></name>, <name><surname>Claxton</surname><given-names>JR</given-names></name>, <etal/>
<article-title>Prospective cohort study reveals unexpected aetiologies of livestock abortion in northern Tanzania</article-title>. <source>Sci Rep</source>
<year>2022</year>; <volume>12</volume>:<fpage>11669</fpage>.<pub-id pub-id-type="pmid">35803982</pub-id>
</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>de Glanville</surname><given-names>WA</given-names></name>, <name><surname>Allan</surname><given-names>KJ</given-names></name>, <name><surname>Nyarobi</surname><given-names>JM</given-names></name>, <etal/>
<article-title>An outbreak of Rift Valley fever among peri-urban dairy cattle in northern Tanzania</article-title>. <source>Trans R Soc Trop Med Hyg</source>; <year>2022</year>
<volume>116</volume>:<fpage>1082</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">36040309</pub-id>
</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Costales</surname><given-names>C</given-names></name>, <name><surname>Crump</surname><given-names>JA</given-names></name>, <name><surname>Mremi</surname><given-names>AR</given-names></name>, <etal/>
<article-title>Performance of Xpert Ultra nasopharyngeal swab for identification of tuberculosis deaths in northern Tanzania</article-title>. <source>Clin Microbiol Infect</source>
<year>2022</year>; <volume>28</volume>:<fpage>1150.e1</fpage>&#x02013;<lpage>.e6</lpage>.</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Madut</surname><given-names>DB</given-names></name>, <name><surname>Rubach</surname><given-names>MP</given-names></name>, <name><surname>Bonnewell</surname><given-names>JP</given-names></name>, <etal/>
<article-title>Trends in fever case management for febrile inpatients in a low malaria incidence setting of Tanzania</article-title>. <source>Trop Med Int Health</source>
<year>2021</year>; <volume>26</volume>: <fpage>1668</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="pmid">34598312</pub-id>
</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Madut</surname><given-names>DB</given-names></name>, <name><surname>Rubach</surname><given-names>MP</given-names></name>, <name><surname>Kalengo</surname><given-names>N</given-names></name>, <etal/>
<article-title>A prospective study of <italic toggle="yes">Escherichia coli</italic> bloodstream infection among adolescents and adults in northern Tanzania</article-title>. <source>Trans R Soc Trop Med Hyg</source>
<year>2020</year>; <volume>114</volume>:<fpage>378</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="pmid">31820810</pub-id>
</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Moorthy</surname><given-names>GS</given-names></name>, <name><surname>Madut</surname><given-names>DB</given-names></name>, <name><surname>Kilonzo</surname><given-names>KG</given-names></name>, <etal/>
<article-title>Antibacterial utilization for febrile illnesses and laboratory-confirmed bloodstream infections in northern Tanzania</article-title>. <source>Open Forum Infect Dis</source>
<year>2023</year>; <volume>10</volume>:<fpage>ofad448</fpage>.<pub-id pub-id-type="pmid">37663090</pub-id>
</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Cutting</surname><given-names>ER</given-names></name>, <name><surname>Simmons</surname><given-names>RA</given-names></name>, <name><surname>Madut</surname><given-names>DB</given-names></name>, <etal/>
<article-title>Facility-based disease surveillance and Bayesian hierarchical modeling to estimate endemic typhoid fever incidence, Kilimanjaro region, Tanzania, 2007&#x02013;2018</article-title>. <source>PLoS Negl Trop Dis</source>
<year>2022</year>; <volume>16</volume>: <fpage>e0010516</fpage>.<pub-id pub-id-type="pmid">35788572</pub-id>
</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Bonnewell</surname><given-names>JP</given-names></name>, <name><surname>Rubach</surname><given-names>MP</given-names></name>, <name><surname>Madut</surname><given-names>DB</given-names></name>, <etal/>
<article-title>Performance assessment of the universal vital assessment score vs other illness severity scores for predicting risk of in-hospital death among adult febrile inpatients in northern Tanzania, 2016&#x02013;2019</article-title>. <source>JAMA Netw Open</source>
<year>2021</year>; <volume>4</volume>:<fpage>e2136398</fpage>.<pub-id pub-id-type="pmid">34913982</pub-id>
</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Ochieng</surname><given-names>C</given-names></name>, <name><surname>Wiersma</surname><given-names>S</given-names></name>, <etal/>
<article-title>Development of a TaqMan array card for acute-febrile-illness outbreak investigation and surveillance of emerging pathogens, including Ebola Virus</article-title>. <source>J Clin Microbiol</source>
<year>2016</year>; <volume>54</volume>:<fpage>49</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="pmid">26491176</pub-id>
</mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Leutenegger</surname><given-names>CM</given-names></name>, <name><surname>Alluwaimi</surname><given-names>AM</given-names></name>, <name><surname>Smith</surname><given-names>WL</given-names></name>, <name><surname>Perani</surname><given-names>L</given-names></name>, <name><surname>Cullor</surname><given-names>JS</given-names></name>. <article-title>Quantitation of bovine cytokine mRNA in milk cells of healthy cattle by real-time TaqMan<sup>&#x000ae;</sup> polymerase chain reaction</article-title>. <source>Vet Immunol Immunopathol</source>; <year>2000</year>
<volume>77</volume>:<fpage>275</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="pmid">11137125</pub-id>
</mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>O&#x02019;Leary</surname><given-names>NA</given-names></name>, <name><surname>Wright</surname><given-names>MW</given-names></name>, <name><surname>Brister</surname><given-names>JR</given-names></name>, <etal/>
<article-title>Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation</article-title>. <source>Nucleic Acids Res</source>
<year>2016</year>; <volume>44</volume>:<fpage>D733</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">26553804</pub-id>
</mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Nguyen</surname><given-names>L-T</given-names></name>, <name><surname>Schmidt</surname><given-names>HA</given-names></name>, <name><surname>von Haeseler</surname><given-names>A</given-names></name>, <name><surname>Minh</surname><given-names>BQ</given-names></name>. <article-title>IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies</article-title>. <source>Mol Biol Evol</source>
<year>2015</year>; <volume>32</volume>:<fpage>268</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">25371430</pub-id>
</mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Bird</surname><given-names>BH</given-names></name>, <name><surname>Khristova</surname><given-names>ML</given-names></name>, <name><surname>Rollin</surname><given-names>PE</given-names></name>, <name><surname>Ksiazek</surname><given-names>TG</given-names></name>, <name><surname>Nichol</surname><given-names>ST</given-names></name>. <article-title>Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry</article-title>. <source>J Virol</source>
<year>2007</year>; <volume>81</volume>:<fpage>2805</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">17192303</pub-id>
</mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Ksiazek</surname><given-names>TG</given-names></name>, <name><surname>Rollin</surname><given-names>PE</given-names></name>, <name><surname>Williams</surname><given-names>AJ</given-names></name>, <etal/>
<article-title>Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995</article-title>. <source>J Infect Dis</source>
<year>1999</year>; <volume>179</volume>(<issue>Suppl 1</issue>):<fpage>S177</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="pmid">9988182</pub-id>
</mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Bryan</surname><given-names>JP</given-names></name>, <name><surname>Iqbal</surname><given-names>M</given-names></name>, <name><surname>Ksiazek</surname><given-names>TG</given-names></name>, <etal/>
<article-title>Prevalence of sand fly fever, West Nile, Crimean-Congo hemorrhagic fever, and leptospirosis antibodies in Pakistani military personnel</article-title>. <source>Mil Med</source>
<year>1996</year>; <volume>161</volume>:<fpage>149</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">8637643</pub-id>
</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Shoemaker</surname><given-names>T</given-names></name>, <name><surname>Boulianne</surname><given-names>C</given-names></name>, <name><surname>Vincent</surname><given-names>MJ</given-names></name>, <etal/>
<article-title>Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000&#x02013;01</article-title>. <source>Emerg Infect Dis</source>; <year>2002</year>
<volume>8</volume>:<fpage>1415</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">12498657</pub-id>
</mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Bird</surname><given-names>BH</given-names></name>, <name><surname>Githinji</surname><given-names>JWK</given-names></name>, <name><surname>Macharia</surname><given-names>JM</given-names></name>, <etal/>
<article-title>Multiple virus lineages sharing recent common ancestry were associated with a Large Rift Valley fever outbreak among livestock in Kenya during 2006&#x02013;2007</article-title>. <source>J Virol</source>
<year>2008</year>; <volume>82</volume>:<fpage>11152</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">18786992</pub-id>
</mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Sindato</surname><given-names>C</given-names></name>, <name><surname>Karimuribo</surname><given-names>ED</given-names></name>, <name><surname>Pfeiffer</surname><given-names>DU</given-names></name>, <etal/>
<article-title>Spatial and temporal pattern of Rift Valley fever outbreaks in Tanzania; 1930 to 2007</article-title>. <source>PLoS One</source>
<year>2014</year>; <volume>9</volume>:<fpage>e88897</fpage>.<pub-id pub-id-type="pmid">24586433</pub-id>
</mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Sun</surname><given-names>Y</given-names></name>, <name><surname>Shi</surname><given-names>W</given-names></name>, <etal/>
<article-title>The first imported case of Rift Valley fever in China reveals a genetic reassortment of different viral lineages</article-title>. <source>Emerg Microbes Infect</source>
<year>2017</year>; <volume>6</volume>:<fpage>e4</fpage>.<pub-id pub-id-type="pmid">28096531</pub-id>
</mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>Pfeffer</surname><given-names>M</given-names></name>, <name><surname>Dobler</surname><given-names>G</given-names></name>. <article-title>Emergence of zoonotic arboviruses by animal trade and migration</article-title>. <source>Parasit Vectors</source>
<year>2010</year>; <volume>3</volume>:<fpage>35</fpage>.<pub-id pub-id-type="pmid">20377873</pub-id>
</mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><name><surname>Gaudreault</surname><given-names>NN</given-names></name>, <name><surname>Indran</surname><given-names>SV</given-names></name>, <name><surname>Balaraman</surname><given-names>V</given-names></name>, <name><surname>Wilson</surname><given-names>WC</given-names></name>, <name><surname>Richt</surname><given-names>JA</given-names></name>. <article-title>Molecular aspects of rift valley fever virus and the emergence of reassortants</article-title>. <source>Virus Genes</source>
<year>2019</year>; <volume>55</volume>:<fpage>1</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">30426314</pub-id>
</mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Kolimenakis</surname><given-names>A</given-names></name>, <name><surname>Heinz</surname><given-names>S</given-names></name>, <name><surname>Wilson</surname><given-names>ML</given-names></name>, <etal/>
<article-title>The role of urbanisation in the spread of aedes mosquitoes and the diseases they transmit&#x02014;a systematic review</article-title>. <source>PLoS Negl Trop Dis</source>
<year>2021</year>; <volume>15</volume>:<fpage>e0009631</fpage>.<pub-id pub-id-type="pmid">34499653</pub-id>
</mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Gerken</surname><given-names>KN</given-names></name>, <name><surname>Mutuku</surname><given-names>FM</given-names></name>, <name><surname>Ndenga</surname><given-names>BA</given-names></name>, <etal/>
<article-title>Urban risk factors for human Rift Valley fever virus exposure in Kenya</article-title>. <source>PLOS Glob Public Health</source>
<year>2022</year>; <volume>2</volume>:<fpage>e0000505</fpage>.<pub-id pub-id-type="pmid">36962424</pub-id>
</mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><name><surname>Grossi-Soyster</surname><given-names>EN</given-names></name>, <name><surname>Lee</surname><given-names>J</given-names></name>, <name><surname>King</surname><given-names>CH</given-names></name>, <name><surname>LaBeaud</surname><given-names>AD</given-names></name>. <article-title>The influence of raw milk exposures on Rift Valley fever virus transmission</article-title>. <source>PLoS Negl Trop Dis</source>
<year>2019</year>; <volume>13</volume>:<fpage>e0007258</fpage>.<pub-id pub-id-type="pmid">30893298</pub-id>
</mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="other"><name><surname>Temur</surname><given-names>AI</given-names></name>, <name><surname>Kuhn</surname><given-names>JH</given-names></name>, <name><surname>Pecor</surname><given-names>DB</given-names></name>, <name><surname>Apanaskevich</surname><given-names>DA</given-names></name>, <name><surname>Keshtkar-Jahromi</surname><given-names>M</given-names></name>. <source>Epidemiology of Crimean-Congo</source></mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Figure 1.</label><caption><p id="P48">Flow chart of participant enrollment and testing for Rift Valley fever virus and Crimean-Congo hemorrhagic fever virus in a prospective cohort study evaluating the etiology of severe and fatal febrile illness, Northern Tanzania, 2016&#x02013;2019. <sup>a</sup>TaqMan acute febrile illness panel detected RVFV in 3 participants enrolled antemortem. <sup>b</sup>Next-generation sequencing detected RVFV in 1 participant enrolled postmortem. <sup>c</sup>Complete genomes available for 11 cattle and 2 human samples. Abbreviations: CCHFV, Crimean-Congo hemorrhagic fever virus; Duke-NUS PEID, Duke-National University of Singapore Program in Emerging Infectious Diseases; KCRI, University of Virginia/Kilimanjaro Clinical Research Institute; RT-qPCR, reverse transcription quantitative polymerase chain reaction; RVFV, Rift Valley fever virus; US CDC VSPD, United States Centers for Disease Control and Prevention Viral Special Pathogen Branch.</p></caption><graphic xlink:href="nihms-2074854-f0001" position="float"/></fig><fig position="float" id="F2"><label>Figure 2.</label><caption><p id="P49">Epidemic curve illustrating human and cattle Rift Valley fever virus infections detected by RT-qPCR in 2018, Kilimanjaro Region, northern Tanzania, 2016&#x02013;2019. Abbreviations: RT-qPCR, reverse transcription quantitative polymerase chain reaction; RVFV, Rift Valley fever virus.</p></caption><graphic xlink:href="nihms-2074854-f0002" position="float"/></fig><fig position="float" id="F3"><label>Figure 3.</label><caption><p id="P50">Location of 4 human and 14 cattle Rift Valley fever virus infections in northern Tanzania: (<italic toggle="yes">A</italic>) ward location of cases is gray shaded, (<italic toggle="yes">B</italic>) Tanzania with the Kilimanjaro and Manyara Regions outlined, and (<italic toggle="yes">C</italic>) Moshi Urban is outlined.</p></caption><graphic xlink:href="nihms-2074854-f0003" position="float"/></fig><fig position="float" id="F4"><label>Figure 4.</label><caption><p id="P51">Phylogenetic analysis of complete L segment of Rift Valley fever virus strains obtained from infected humans and cattle in northern Tanzania, 2018. The scale bar shows branch length per unit of 0.01 substitutions per site. Sequences are labeled with GenBank accession number and designated strain names with country and year of origin. Sequences from this study and the previous cattle outbreak study are highlighted in bold with unique study identifiers and species of origin. Lineages of viral lineages are labeled according to Bird et al [<xref rid="R25" ref-type="bibr">25</xref>].</p></caption><graphic xlink:href="nihms-2074854-f0004" position="float"/></fig><table-wrap position="float" id="T1" orientation="landscape"><label>Table 1.</label><caption><p id="P52">Sociodemographic and Clinical Characteristics of Hospitalized Participants Enrolled in a Prospective Cohort Study Evaluating the Etiology of Severe and Fatal Febrile Illness and Tested for RVFV and CCHFV, Northern Tanzania, 2016&#x02013;2019</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Variables</th><th align="center" valign="bottom" rowspan="1" colspan="1">Entire Cohort (n = 656)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Antemortem Enrollment (n = 537)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Postmortem Enrollment (n = 119)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sociodemographics</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Age, y, mean (range)</td><td align="center" valign="middle" rowspan="1" colspan="1">30 (1&#x02013;96)</td><td align="center" valign="middle" rowspan="1" colspan="1">27 (1&#x02013;92)</td><td align="center" valign="middle" rowspan="1" colspan="1">43 (1&#x02013;96)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Female, n (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">302 (46.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">254 (47.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">48 (40.3)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Cattle contact, n (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">170 (26.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">118 (22.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">52 (46.0)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RVFV laboratory findings</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;RVFV IgG positive, n (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">8 (1.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">8 (1.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;RVFV RT-qPCR positive, n (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (0.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">3 (0.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (0.8)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CCHFV laboratory findings</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;CCHFV IgG positive, n (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">5 (0.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">5 (0.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;CCHFV RT-qPCR positive, n (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Vital outcome</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;In-hospital mortality, n (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">119 (18.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">119.0 (100.0)</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P53">Abbreviations: CCHFV, Crimean-Congo hemorrhagic fever virus; IgG, immunoglobulin G; RT-qPCR, reverse transcription quantitative polymerase chain reaction; RVFV, Rift Valley fever virus.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2.</label><caption><p id="P54">Demographic, Clinical, and Laboratory Characteristics of 4 RVFV RT-qPCR&#x02013;Positive Human Participants Enrolled in a Prospective Cohort Study Evaluating the Etiologies of Febrile Illness in the Kilimanjaro Region, Northern Tanzania, 2018</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Enrollment</th><th align="center" valign="bottom" rowspan="1" colspan="1">Age, y</th><th align="center" valign="bottom" rowspan="1" colspan="1">Sex</th><th align="center" valign="bottom" rowspan="1" colspan="1">Cattle Contact</th><th align="center" valign="bottom" rowspan="1" colspan="1">TAC AFI PCR</th><th align="center" valign="bottom" rowspan="1" colspan="1">RVFV-IgG</th><th align="center" valign="bottom" rowspan="1" colspan="1">NGS</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Antemortem</td><td align="center" valign="middle" rowspan="1" colspan="1">55</td><td align="left" valign="middle" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">NA<sup><xref rid="TFN4" ref-type="table-fn">a</xref></sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Antemortem</td><td align="center" valign="middle" rowspan="1" colspan="1">28</td><td align="left" valign="middle" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">NA<sup><xref rid="TFN4" ref-type="table-fn">a</xref></sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Antemortem</td><td align="center" valign="middle" rowspan="1" colspan="1">57</td><td align="left" valign="middle" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">NA<sup><xref rid="TFN4" ref-type="table-fn">a</xref></sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Postmortem</td><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td align="left" valign="middle" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">NA<sup><xref rid="TFN4" ref-type="table-fn">a</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>+</bold>
</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p id="P55">+, present or detected; &#x02212;, not present or not detected.</p></fn><fn id="TFN3"><p id="P56">Abbreviations: IgG, immunoglobulin G; NA, not available; NGS, next-generation sequencing; RT-qPCR, reverse transcription quantitative polymerase chain reaction; RVFV, Rift Valley fever virus; TAC AFI PCR, TaqMan array card acute febrile illness PCR panel.</p></fn><fn id="TFN4"><label>a</label><p id="P57">TAC AFI were not performed on postmortem enrollments, and NGS was not performed on antemortem enrollments.</p></fn></table-wrap-foot></table-wrap></floats-group></article>